ONTX   $0.9012  -1.50% Market Closed

Onconova Therapeutics Inc
Total Cash 25.24M
totalCashPerShare 1.202
EBITDA -21.55M
Total Debt 0.00
quickRatio 2.611
currentRatio 2.792
Total Revenue 226.00K
debtToEquity
Revenue/Share 0.011
ROA -0.38073003
ROE -0.84296995
grossProfits
freeCashflow -10.47M
operatingCashflow -17.39M
earningsGrowth
revenueGrowth 0.0
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -89.2807
profitMargins 0.0
enterpriseValue -4.87M
forwardPE -1.1573255
floatShares 20.84M
sharesOutstanding 21.00M
sharesShort 20.70K
sharesShortPriorMonth 31.06K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.08%
Short Ratio help_outline 0.19%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.691
Price To Book help_outline 1.44
earningsQuarterlyGrowth
netIncomeToCommon -20.18M
trailingEps -0.96%
forwardEps -0.86%
enterpriseToEbitda 0.23
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 1Q 2024
institutionsCount 30
lastUpdated April 11, 2024, 1:45 p.m.